79126292 - ENTEROME

Information

• Trademark
• 79126292

• Source

• Serial Number

  79126292

• Registration Number

  4561761

• International Classifications

  • 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry
  • 3 - Bleaching preparations and other substances for laundry use
  • 5 - Pharmaceutical and veterinary preparations
  • 42 - Scientific and technological services and research and design relating thereto

• Filing Date

  January 03, 2013
  12 years ago

• Registration Date

  July 08, 2014
  10 years ago

• Transaction Date

  December 10, 2024
  a month ago

• Status Date

  February 10, 2021
  3 years ago

• Published for Opposition Date

  January 14, 2014
  11 years ago

• Location Date

  February 10, 2021
  3 years ago

• Status Code

  708

• Employee Name

  TANNER, MICHAEL

• Attorney Docket Number

  REGIM.273

  Attorney Name

  Thomas M. Palisi

  Law Office Assigned Location Code

  N10

• Owners

  • ENTEROME S.A.

Case File Statements

• GS0051: Pharmaceutical and medicinal products for human and veterinary use, namely, pharmaceutical preparations for treating metabolic disorders, immunological disorders, cancers, central nervous systems disorders, gastroenterological disorders, infectious diseases, diarrhea, constipation and irritable bowel syndrome; veterinary products, namely, anti-infective products for veterinary use, veterinary pharmaceutical preparations for treatment of metabolic disorders, immunological disorders, cancers, central nervous systems disorders, gastroenterological disorders, infectious diseases and diarrhea; medicinal products for human and veterinary use, namely, nutritional supplements containing probiotic compositions; sanitary products for use in medicine, namely, sanitary sterilizing preparations, disinfectants for sanitary purposes, sanitary preparations for medical use; dietetic food and substances for medical use in the nature of meal replacement products and prepackaged meal plans, namely, nutritional meal replacement bars adapted for medical use for treating metabolic disorders, immunological disorders, central nervous systems disorders, gastroenterological disorders, infectious diseases, diarrhea, constipation and irritable bowel syndrome, prepared, prepackaged entrees for medical use for treating metabolic disorders, immunological disorders, central nervous systems disorders, gastroenterological disorders, infectious diseases, diarrhea, constipation and irritable bowel syndrome, prepared, prepackaged snack foods for medical use for treating metabolic disorders, immunological disorders, central nervous systems disorders, gastroenterological disorders, infectious diseases, diarrhea, constipation and irritable bowel syndrome, prepared, prepackaged yogurts for medical use for treating metabolic disorders, immunological disorders, central nervous systems disorders, gastroenterological disorders, infectious diseases, diarrhea, constipation and irritable bowel syndrome, prepared, prepackaged desserts for medical use for treating metabolic disorders, immunological disorders, central nervous systems disorders, gastroenterological disorders, infectious diseases, diarrhea, constipation and irritable bowel syndrome; nutritional supplements for medical use; food additives for medical use, namely, dietary fiber for treating metabolic disorders, gastroenterological disorders, diarrhea, constipation and irritable bowel syndrome; nutritional food additives for medical purposes in the nature of natural food extracts derived from fish, meat, vegetables, microorganisms and crops
• GS0031: [ Cosmetic products, namely, cosmetic creams ]
• GS0011: [ Chemical and biochemical substances used for the manufacture and preservation of foodstuffs, of pharmaceutical, cosmetic and veterinary products, namely, probiotic bacteria and probiotic bacterial cultures for use in the manufacture of food products and pharmaceutical preparations, prebiotic bacteria and prebiotic bacterial cultures for use in the manufacture of food products and pharmaceutical preparations, enzymes for use in the manufacture of food products and pharmaceutical preparations ]
• GS0421: Human pharmaceutical research; research services provided by a pharmaceutical laboratory, namely, providing medical research testing services in the field of metabolic disorders, immunological disorders, central nervous systems disorders, gastroenterological disorders, infectious diseases, diarrhea, constipation, and irritable bowel syndrome; Providing medical and scientific research information in the field of metabolic disorders, immunological disorders, central nervous systems disorders, gastroenterological disorders, infectious diseases, diarrhea, constipation, and irritable bowel syndrome; providing medical and scientific research information in the field of pharmaceutical and clinical trials; scientific laboratory services, genetic testing of laboratory animals for pharmaceutical research purposes; biological research in the fields of microbiology and chemistry

Case File Event Statements

• 3/15/2013 - 11 years ago

  3 - APPLICATION FILING RECEIPT MAILED Type: MAFR

• 4/17/2013 - 11 years ago

  4 - ASSIGNED TO EXAMINER Type: DOCK

• 4/19/2013 - 11 years ago

  5 - NON-FINAL ACTION WRITTEN Type: CNRT

• 4/22/2013 - 11 years ago

  7 - REFUSAL PROCESSED BY MPU Type: RFRR

• 3/7/2013 - 11 years ago

  1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR

• 3/11/2013 - 11 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 4/20/2013 - 11 years ago

  6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR

• 4/22/2013 - 11 years ago

  8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS

• 11/7/2013 - 11 years ago

  13 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 12/6/2013 - 11 years ago

  15 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV

• 12/25/2013 - 11 years ago

  17 - NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Type: OP2R

• 5/15/2013 - 11 years ago

  9 - REFUSAL PROCESSED BY IB Type: RFNP

• 10/22/2013 - 11 years ago

  10 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA

• 10/22/2013 - 11 years ago

  11 - EXAMINER'S AMENDMENT ENTERED Type: XAEC

• 10/22/2013 - 11 years ago

  12 - EXAMINERS AMENDMENT MAILED Type: CNEA

• 12/2/2013 - 11 years ago

  14 - ASSIGNED TO LIE Type: ALIE

• 12/25/2013 - 11 years ago

  16 - NOTICE OF PUBLICATION Type: NPUB

• 12/25/2013 - 11 years ago

  18 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS

• 1/11/2014 - 11 years ago

  19 - NOTIFICATION PROCESSED BY IB Type: GPNX

• 7/8/2014 - 10 years ago

  23 - REGISTERED-PRINCIPAL REGISTER Type: R.PR

• 12/4/2014 - 10 years ago

  26 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS

• 1/23/2015 - 9 years ago

  27 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINO

• 1/14/2014 - 11 years ago

  20 - PUBLISHED FOR OPPOSITION Type: PUBO

• 2/12/2014 - 10 years ago

  21 - EXTENSION OF TIME TO OPPOSE RECEIVED Type: ETOF

• 5/30/2014 - 10 years ago

  22 - EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED Type: ETOP

• 10/8/2014 - 10 years ago

  24 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR

• 12/4/2014 - 10 years ago

  25 - FINAL DISPOSITION PROCESSED Type: FIMP

• 12/29/2020 - 4 years ago

  28 - TEAS SECTION 71 & 15 RECEIVED Type: ES75

• 2/10/2021 - 3 years ago

  29 - CASE ASSIGNED TO POST REGISTRATION PARALEGAL Type: APRE

• 2/10/2021 - 3 years ago

  30 - REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK. Type: C75P

• 2/10/2021 - 3 years ago

  31 - NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED Type: NA75

• 10/10/2021 - 3 years ago

  32 - PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED Type: INPR

• 11/4/2021 - 3 years ago

  33 - INVALIDATION PROCESSED Type: INPC

• 11/4/2021 - 3 years ago

  34 - PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB Type: INPS

• 1/26/2023 - a year ago

  36 - INTERNATIONAL REGISTRATION RENEWED Type: RNWL

• 7/8/2023 - a year ago

  37 - COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED Type: REM4

• 12/9/2024 - a month ago

  38 - TEAS SECTION 71 RECEIVED Type: ES71

• 12/12/2021 - 3 years ago

  35 - PARTIAL INVALIDATION PROCESSED BY THE IB Type: INNP